Filing Details
- Accession Number:
- 0001209191-23-011047
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-21 12:38:45
- Reporting Period:
- 2023-02-16
- Accepted Time:
- 2023-02-21 12:38:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1652724 | Lucira Health Inc. | LHDX | In Vitro & In Vivo Diagnostic Substances (2835) | 272491037 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1877741 | Ghazi Kashmolah | 1412 62Nd Street Emeryville CA 94608 | Ex Vp & Chief Quality Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-16 | 5,028 | $0.27 | 134,075 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Unitsgranted on September 30,2021 for 197,240 shares.
Billionaire Hedge Funds
